Heron Therapeutics (HRTX) Debt Ratio (2016 - 2025)
Historic Debt Ratio for Heron Therapeutics (HRTX) over the last 5 years, with Q3 2025 value amounting to 0.43.
- Heron Therapeutics' Debt Ratio rose 28393.34% to 0.43 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.43, marking a year-over-year increase of 28393.34%. This contributed to the annual value of 0.11 for FY2024, which is 156.29% down from last year.
- According to the latest figures from Q3 2025, Heron Therapeutics' Debt Ratio is 0.43, which was up 28393.34% from 0.11 recorded in Q1 2025.
- In the past 5 years, Heron Therapeutics' Debt Ratio registered a high of 0.43 during Q3 2025, and its lowest value of 0.1 during Q3 2023.
- For the 3-year period, Heron Therapeutics' Debt Ratio averaged around 0.15, with its median value being 0.11 (2023).
- Within the past 5 years, the most significant YoY rise in Heron Therapeutics' Debt Ratio was 28393.34% (2025), while the steepest drop was 468.2% (2025).
- Quarter analysis of 3 years shows Heron Therapeutics' Debt Ratio stood at 0.11 in 2023, then dropped by 1.56% to 0.11 in 2024, then skyrocketed by 302.24% to 0.43 in 2025.
- Its Debt Ratio was 0.43 in Q3 2025, compared to 0.11 in Q1 2025 and 0.11 in Q4 2024.